Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05850676 · ClinicalTrials.gov registry record
Disentangling the Role of Depression in Hypersomnia
A clinical trial of Hypersomnia, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT05850676: Recruiting study of Hypersomnia, sponsored by University of Pennsylvania.
NCT05850676 is a study of Hypersomnia that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05850676, a study of Hypersomnia, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals who have disorders of hypersomnolence (excessive sleepiness) often report symptoms of depression. The goal of this study is to further understand of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward function.
Primary Outcome
Scores on the Hamilton Depression Inventory. Scores range from 0 to 52, with higher scores indiated more severe symptoms of depression.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Sleep study
Study Locations (1)
Pennsylvania
- The University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2026-06-30 |
What NCT05850676 shows while recruiting
NCT05850676 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 1 condition, with Hypersomnia appearing as the primary indexed condition, and to 1 intervention - of which Sleep study is the first listed.
NCT05850676 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05850676 about?
NCT05850676 is a clinical study titled "Disentangling the Role of Depression in Hypersomnia". Individuals who have disorders of hypersomnolence (excessive sleepiness) often report symptoms of depression. The goal of this study is to further understand of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward function.
What is the current status of trial NCT05850676?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2023-08-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05850676 study?
This clinical trial studies the following conditions: Hypersomnia.
What interventions are being tested in trial NCT05850676?
The interventions under investigation include: Sleep study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05850676?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05850676 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI